242 related articles for article (PubMed ID: 28869448)
1. Large intergenic non-coding RNA-ROR as a potential biomarker for the diagnosis and dynamic monitoring of breast cancer.
Zhao T; Wu L; Li X; Dai H; Zhang Z
Cancer Biomark; 2017 Aug; 20(2):165-173. PubMed ID: 28869448
[TBL] [Abstract][Full Text] [Related]
2. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
[TBL] [Abstract][Full Text] [Related]
3. Detection and analysis of circulating large intergenic non-coding RNA regulator of reprogramming in plasma for breast cancer.
Zhang K; Luo Z; Zhang Y; Wang Y; Cui M; Liu L; Zhang L; Liu J
Thorac Cancer; 2018 Jan; 9(1):66-74. PubMed ID: 29090518
[TBL] [Abstract][Full Text] [Related]
4. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
5. [Long non-coding RNA HOTAIR in plasma as a potential biomarker for breast cancer diagnosis].
Zhang KJ; Zhang Y; Luo ZL; Liu L; Yang J; Wu LC; Yu SS; Liu JB
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):488-92. PubMed ID: 27113175
[TBL] [Abstract][Full Text] [Related]
6. Linc-ROR induces epithelial-mesenchymal transition and contributes to drug resistance and invasion of breast cancer cells.
Chen YM; Liu Y; Wei HY; Lv KZ; Fu P
Tumour Biol; 2016 Aug; 37(8):10861-70. PubMed ID: 26883251
[TBL] [Abstract][Full Text] [Related]
7. Downregulated Expression of linc-ROR in Gastric Cancer and Its Potential Diagnostic and Prognosis Value.
Yu X; Ding H; Shi Y; Yang L; Zhou J; Yan Z; Xiao B
Dis Markers; 2020; 2020():7347298. PubMed ID: 33163123
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
9. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer.
Peng WX; Huang JG; Yang L; Gong AH; Mo YY
Mol Cancer; 2017 Oct; 16(1):161. PubMed ID: 29041978
[TBL] [Abstract][Full Text] [Related]
10. Expression profiling of long non-coding RNA identifies linc-RoR as a prognostic biomarker in oral cancer.
Arunkumar G; Deva Magendhra Rao AK; Manikandan M; Arun K; Vinothkumar V; Revathidevi S; Rajkumar KS; Rajaraman R; Munirajan AK
Tumour Biol; 2017 Apr; 39(4):1010428317698366. PubMed ID: 28443494
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ROR is a novel prognosis factor associated with non-small-cell lung cancer progression.
Qu CH; Sun QY; Zhang FM; Jia YM
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4087-4091. PubMed ID: 29028092
[TBL] [Abstract][Full Text] [Related]
12. Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer.
Zhang L; Song X; Wang X; Xie Y; Wang Z; Xu Y; You X; Liang Z; Cao H
Breast Cancer Res Treat; 2015 Jul; 152(1):199-208. PubMed ID: 26033707
[TBL] [Abstract][Full Text] [Related]
13. Potential Diagnostic Value of Plasma Long-Chain Non-Coding RNA HIT in Breast Cancer.
Hou H; Li F; Yang W; Wang H
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414748
[TBL] [Abstract][Full Text] [Related]
14. Circulating long noncoding RNA GAS5 as a potential biomarker in breast cancer for assessing the surgical effects.
Han L; Ma P; Liu SM; Zhou X
Tumour Biol; 2016 May; 37(5):6847-54. PubMed ID: 26662314
[TBL] [Abstract][Full Text] [Related]
15. Expression of long intergenic non-coding RNA, regulator of reprogramming, and its prognostic value in patients with glioblastoma.
Toraih EA; El-Wazir A; Hussein MH; Khashana MS; Matter A; Fawzy MS; Hosny S
Int J Biol Markers; 2019 Mar; 34(1):69-79. PubMed ID: 30852975
[TBL] [Abstract][Full Text] [Related]
16. [Expression and function of long intergenic non-protein coding RNA-regulator of reprogramming in high-grade ovarian serous cancer].
Jiang HH; Lou YH; Wang XY; Han Y; Cui ZM
Zhonghua Fu Chan Ke Za Zhi; 2016 Dec; 51(12):921-927. PubMed ID: 28057128
[No Abstract] [Full Text] [Related]
17. Expression of long non-coding RNA linc-ITGB1 in breast cancer and its influence on prognosis and survival.
Li WX; Sha RL; Bao JQ; Luan W; Su RL; Sun SR
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3397-3401. PubMed ID: 28829502
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of LINC-ROR in cancer cell lines and tissues.
Rezaei M; Emadi-Baygi M; Hoffmann MJ; Schulz WA; Nikpour P
Tumour Biol; 2016 Feb; 37(2):1763-9. PubMed ID: 26314857
[TBL] [Abstract][Full Text] [Related]
19. Circulating HOTAIR expression predicts the clinical response to neoadjuvant chemotherapy in patients with breast cancer.
Lu R; Zhang J; Zhang W; Huang Y; Wang N; Zhang Q; Qu S
Cancer Biomark; 2018; 22(2):249-256. PubMed ID: 29630518
[TBL] [Abstract][Full Text] [Related]
20. Long intergenic non-coding RNA, regulator of reprogramming (LINC-ROR) over-expression predicts poor prognosis in renal cell carcinoma.
Fawzy MS; Toraih EA; El-Wazir A; Hosny MM; Badran DI; El Kelish A
Arch Med Sci; 2021; 17(4):1016-1027. PubMed ID: 34336029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
